Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.
Schoch LK, Asiama A, Zahurak M, Shanbhag S, Hurtt J, Sawyer K, Swinnen LJ, Wagner-Johnston N, Jones RJ, Ambinder RF, Gladstone DE.
Schoch LK, et al. Among authors: hurtt j.
Cancer Chemother Pharmacol. 2018 Feb;81(2):347-354. doi: 10.1007/s00280-017-3499-y. Epub 2017 Dec 13.
Cancer Chemother Pharmacol. 2018.
PMID: 29234922